Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice

被引:61
作者
Van den Haute, C
Spittaels, K
Van Dorpe, J
Lasrado, R
Vandezande, K
Laenen, I
Geerts, H
Van Leuven, F
机构
[1] Katholieke Univ Leuven VIB, Ctr Human Genet, Expt Genet Grp, B-3000 Louvain, Belgium
[2] Janssen Res Fdn, B-2340 Beerse, Belgium
关键词
D O I
10.1006/nbdi.2000.0333
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The potential contribution of cyclin-dependent protein kinase 5 (cdk5) to hyperphosphorylate protein tau, as claimed in Alzheimer's disease, was investigated in vivo. We generated single, double, and triple transgenic mice that coexpress human cdk5 and its activator p35 as well as human protein tau in cerebral neurons. Whereas expression and increased cdk5-kinase activity was obtained, as measured in vitro and demonstrated in vivo neither murine nor human protein tau was appreciably phosphorylated in the brain of double and triple transgenic mice. These mice behaved and reproduced normally. Silver impregnation and immunohistochemistry of brain sections demonstrated that neurofilament proteins became redistributed in apical dendrites of cortical neurons. This suggested a cytoskeletal effect, but no other relevant brain pathology became apparent. These observations indicate that cdk5/p35 is not a major protein tau kinase and that cdk5/p35 did not cause neurodegeneration in mouse brain, as opposed to cdk5/p25. (C) 2001 Academic Press.
引用
收藏
页码:32 / 44
页数:13
相关论文
共 55 条
[1]   Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 [J].
Ahlijanian, MK ;
Barrezueta, NX ;
Williams, RD ;
Jakowski, A ;
Kowsz, KP ;
McCarthy, S ;
Coskran, T ;
Carlo, A ;
Seymour, PA ;
Burkhardt, JE ;
Nelson, RB ;
McNeish, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2910-2915
[2]  
[Anonymous], 1994, MANIPULATING MOUSE E
[3]  
Bajaj NPS, 1997, J NEUROCHEM, V69, P737
[4]   ABNORMAL ALZHEIMER-LIKE PHOSPHORYLATION OF TAU-PROTEIN BY CYCLIN-DEPENDENT KINASES CDK2 AND CDK5 [J].
BAUMANN, K ;
MANDELKOW, EM ;
BIERNAT, J ;
PIWNICAWORMS, H ;
MANDELKOW, E .
FEBS LETTERS, 1993, 336 (03) :417-424
[5]   THE SWITCH OF TAU-PROTEIN TO AN ALZHEIMER-LIKE STATE INCLUDES THE PHOSPHORYLATION OF 2 SERINE PROLINE MOTIFS UPSTREAM OF THE MICROTUBULE BINDING REGION [J].
BIERNAT, J ;
MANDELKOW, EM ;
SCHROTER, C ;
LICHTENBERGKRAAG, B ;
STEINER, B ;
BERLING, B ;
MEYER, H ;
MERCKEN, M ;
VANDERMEEREN, A ;
GOEDERT, M ;
MANDELKOW, E .
EMBO JOURNAL, 1992, 11 (04) :1593-1597
[6]   AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease [J].
BueeScherrer, V ;
Condamines, O ;
MourtonGilles, C ;
Jakes, R ;
Goedert, M ;
Pau, B ;
Delacourte, A .
MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2) :79-88
[7]   Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality [J].
Chae, T ;
Kwon, YT ;
Bronson, R ;
Dikkes, P ;
Li, E ;
Tsai, LH .
NEURON, 1997, 18 (01) :29-42
[8]   Temporal and spatial patterns of expression of p35, a regulatory subunit of cyclin-dependent kinase 5, in the nervous system of the mouse [J].
Delalle, I ;
Bhide, PG ;
Caviness, VS ;
Tsai, LH .
JOURNAL OF NEUROCYTOLOGY, 1997, 26 (05) :283-296
[9]  
ELHANANY E, 1994, J NEUROCHEM, V63, P2324
[10]  
Gao CY, 1997, DEV GENET, V20, P267